Boger RH (2007): The Pharmacodynamics of L-Arginine. Nutr; 137: 1650S-1655S.Boger RH.The pharmacodynamics of L-arginine[J].2014,20.Boger RH. The pharmacodynamics of L-arginine. Altern Ther Health Med 2014; 20: 48-54.Boger RH . The pharmacodynamics of L-arginine [J]. 2014,20 ....
The pharmacodynamics of L-arginine L-Arginine is a precursor for nitric oxide (NO) synthesis. NO is a ubiquitous mediator that is formed by a family of enzymes called NO synthases (NOSs). In the brain, NO acts as a neurotransmitter; in the immune system, it acts as a medi... Bger,...
Pharmacokinetics and pharmacodynamics of the three isomers of mivacurium in health, in end-stage renal failure and in patients with impaired renal function. We have studied the pharmacokinetics of cis-trans, trans-trans and cis-cis mivacurium in nine healthy patients (creatinine clearance 66-133 ml...
L(+)-Arginine: Function, source and pharmacodynamics Apr 25, 2023 L(+)-Arginine is one of the most versatile amino acids in animal cells, serving as a precursor for the synthesis not only of proteins but also of nitric oxide, urea, polyamines, and proline. Uses of L-Arginine Oct 22,...
[48]. Collectively, these attributes synergistically enhance the pharmacokinetics and pharmacodynamics of active compounds. Furthermore, a diverse array of nanomaterials is already being used to overcome the limitations of lung therapies. The substantial absorption, extensive circulation, and permeability of...
Organic anion transporting polypeptides OATP1B1 and OATP1B3 and their genetic variants influence the pharmacokinetics and pharmacodynamics of raloxifene J Transl Med, 10 (2012), p. 76 View in ScopusGoogle Scholar 128 X. Zhou, S. Wang, H. Sun, B. Wu Sulfonation of raloxifene in HEK293 cells...
Ariëns EJ, van Rossum JM (1957) pDx, pAx and pD′x values in the analysis of pharmacodynamics. Arch Int Pharmacodyn 110:275–299 PubMed Google Scholar Armitage AK, Vane JR (1964) A sensitive method for the assay of catechol amines. Br J Pharmacol 22:204–210 CAS Google Scholar ...
Most biopharmaceuticals are developed in liquid dosage forms that are less stable than solid forms. To ensure the stability of biopharmaceuticals, it is cr
1The pharmacokinetics and pharmacodynamics of intranasal (IN) and oral 1-deamino-8-d-arginine vasopressin (DDAVP) were compared in 10 Chinese adults with c... K.,S.,L.,... - 《British Journal of Clinical Pharmacology》 被引量: 73发表: 1996年 Collecting Duct‐Specific Knockout of Adenylyl...
This review focuses on the impact of the gut microbiome on drug disposition and the pharmacokinetics and pharmacodynamics for select drugs. Digoxin, irinotecan, immune checkpoint inhibitors, levodopa, and nonsteroidal anti-inflammatory drugs affected by microbiome alterations with potential clinical impact ...